Yale School of Medicine (YSM) was ranked fourth in the nation for total National Institutes of Health (NIH) funding in the most recently released rankings by the Blue Ridge Institute for Medical Research (BRIMR).
BRIMR, a non-profit organization based in North Carolina, compiles the medical school rankings in NIH funding each year. In the federal fiscal year 2023, which ended September 30, 2023, YSM researchers received a total of $571,450,883 in awards. This is an increase of nearly 4% from 2022, in which YSM received $549,914,436 and ranked seventh.
YSM’s ranking reflects how well-aligned our research is with national priorities in biomedical health research.
Anthony Koleske, PhD
“YSM’s ranking reflects how well-aligned our research is with national priorities in biomedical health research,” says Anthony Koleske, PhD, Ensign Professor of Molecular Biophysics & Biochemistry and deputy dean for research (basic science). “It also reflects the strength of our faculty, who are studying the most important questions in biomedical research.”
YSM has many priorities for research, including inflammation, single cell biology, metabolism, developmental brain disorders, health equity, technology and biomedical engineering, biomedical & biological imaging, and translational medicine/clinical trials, as well as others identified by Yale’s University Science Strategy Committee (USSC).
“A core mission at YSM is to enable our researchers to pursue their interests and goals,” says Koleske. “YSM is dedicated to recruiting and supporting top researchers, offering infrastructure that allows them to thrive, and facilitating collaboration among different groups as much as possible. We also would like to facilitate teams of scientists working together to address larger and more impactful questions.”
The rise in ranking would not be possible without YSM’s hardworking faculty, Koleske says. “We’re hiring world leaders in all fields,” he adds. “They are the drivers of this success.”